275 related articles for article (PubMed ID: 2039437)
21. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor.
Castor CW; Miller JW; Walz DA
Proc Natl Acad Sci U S A; 1983 Feb; 80(3):765-9. PubMed ID: 6572368
[TBL] [Abstract][Full Text] [Related]
22. Molecular cloning and characterisation of a neutrophil chemotactic protein from porcine platelets.
Power CA; Proudfoot AE; Magnenat E; Bacon KB; Wells TN
Eur J Biochem; 1994 Apr; 221(2):713-9. PubMed ID: 7513641
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets.
Goel MS; Diamond SL
J Biol Chem; 2003 Mar; 278(11):9458-63. PubMed ID: 12524437
[TBL] [Abstract][Full Text] [Related]
24. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
Reddigari SR; Kuna P; Miragliotta GF; Kornfeld D; Baeza ML; Castor CW; Kaplan AP
J Allergy Clin Immunol; 1992 Mar; 89(3):666-72. PubMed ID: 1372016
[TBL] [Abstract][Full Text] [Related]
25. Connective tissue activation. XXXIII. Biologically active cleavage products of CTAP-III from human platelets.
Castor CW; Walz DA; Ragsdale CG; Hossler PA; Smith EM; Bignall MC; Aaron BP; Mountjoy K
Biochem Biophys Res Commun; 1989 Sep; 163(2):1071-8. PubMed ID: 2783111
[TBL] [Abstract][Full Text] [Related]
26. Amino acids and peptides. XXVIII. Synthesis of peptide fragments related to eglin c and studies on the relationship between their structure and effects on human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
Tsuboi S; Nakabayashi K; Matsumoto Y; Teno N; Tsuda Y; Okada Y; Nagamatsu Y; Yamamoto J
Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2369-76. PubMed ID: 2285973
[TBL] [Abstract][Full Text] [Related]
27. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB
J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656
[TBL] [Abstract][Full Text] [Related]
28. Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein.
Savage MJ; Iqbal M; Loh T; Trusko SP; Scott R; Siman R
Neuroscience; 1994 Jun; 60(3):607-19. PubMed ID: 7936190
[TBL] [Abstract][Full Text] [Related]
29. A possible receptor-binding function for the N-terminus of connective tissue activating peptide III.
Erickson J; Davis LE; Castor CW; Walz DA; Anderson BE
Biochemistry; 1990 May; 29(17):4077-80. PubMed ID: 2141792
[TBL] [Abstract][Full Text] [Related]
30. Leukoproteinases and pulmonary emphysema: cathepsin G and other chymotrypsin-like proteinases enhance the elastolytic activity of elastase on lung elastin.
Boudier C; Laurent P; Bieth JG
Adv Exp Med Biol; 1984; 167():313-7. PubMed ID: 6369910
[No Abstract] [Full Text] [Related]
31. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
Leonard EJ; Yoshimura T; Rot A; Noer K; Walz A; Baggiolini M; Walz DA; Goetzl EJ; Castor CW
J Leukoc Biol; 1991 Mar; 49(3):258-65. PubMed ID: 1997632
[TBL] [Abstract][Full Text] [Related]
32. Structural requirements of platelet chemokines for neutrophil activation.
Yan Z; Zhang J; Holt JC; Stewart GJ; Niewiarowski S; Poncz M
Blood; 1994 Oct; 84(7):2329-39. PubMed ID: 7919350
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
Mitsudo K; Jayakumar A; Henderson Y; Frederick MJ; Kang Y; Wang M; El-Naggar AK; Clayman GL
Biochemistry; 2003 Apr; 42(13):3874-81. PubMed ID: 12667078
[TBL] [Abstract][Full Text] [Related]
34. Zymogen activation specificity and genomic structures of human neutrophil elastase and cathepsin G reveal a new branch of the chymotrypsinogen superfamily of serine proteinases.
Salvesen G; Enghild JJ
Biomed Biochim Acta; 1991; 50(4-6):665-71. PubMed ID: 1801740
[TBL] [Abstract][Full Text] [Related]
35. Identification of possible inhibitory reactive centers in thrombospondin 1 that may bind cathepsin G and neutrophil elastase.
Hogg PJ; Jiménez BM; Chesterman CN
Biochemistry; 1994 May; 33(21):6531-7. PubMed ID: 8204588
[TBL] [Abstract][Full Text] [Related]
36. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
37. The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation.
Brandt E; Petersen F; Ludwig A; Ehlert JE; Bock L; Flad HD
J Leukoc Biol; 2000 Apr; 67(4):471-8. PubMed ID: 10770278
[TBL] [Abstract][Full Text] [Related]
38. Enzymatic generation of the amino terminus of the beta-amyloid peptide.
Sahasrabudhe SR; Brown AM; Hulmes JD; Jacobsen JS; Vitek MP; Blume AJ; Sonnenberg JL
J Biol Chem; 1993 Aug; 268(22):16699-705. PubMed ID: 8344949
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human serine proteases by SPAAT, the C-terminal 44-residue peptide from alpha1-antitrypsin.
Niemann MA; Baggott JE; Miller EJ
Biochim Biophys Acta; 1997 Jun; 1340(1):123-30. PubMed ID: 9217022
[TBL] [Abstract][Full Text] [Related]
40. Connective tissue activation. XXXIV: Effects of proteolytic processing on the biologic activities of CTAP-III.
Castor CW; Walz DA; Johnson PH; Hossler PA; Smith EM; Bignall MC; Aaron BP; Underhill P; Lazar JM; Hudson DH
J Lab Clin Med; 1990 Oct; 116(4):516-26. PubMed ID: 2212861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
